Contrast agents for MR imaging of the liver: a clinical overview

被引：0
|
作者：
A.-E. Mahfouz
B. Hamm
M. Taupitz
机构：
[1] Department of Radiology,
[2] Charité Medical School,undefined
[3] Humboldt-Universität zu Berlin,undefined
[4] Schumannstrasse 20/21,undefined
[5] D-10098 Berlin,undefined
[6] Germany,undefined
[7] Department of Radiology,undefined
[8] Cairo University Hospital,undefined
[9] Cairo,undefined
[10] Egypt,undefined
来源：
European Radiology | 1997年 / 7卷
关键词：
Key words: Magnetic resonance; Contrast agents; Liver neoplasms; Gadolinium; Iron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Different contrast agents have been clinically used in MR imaging of the liver including extracellular gadolinium chelates, contrast agents targeted to the macrophage-monocytic phagocytic system (MMPS), hepatobiliary contrast agents, and blood-pool contrast agents. Extracellular gadolinium chelates are optimally used for characterization of focal hepatic lesions, whereas hepatobiliary and MMPS-targeted contrast agents are optimally used for detection and preoperative evaluation. The present review portrays these contrast agents and discusses their advantages and shortcomings.
引用
收藏
页码：507 / 513
页数：6
相关论文
共 50 条
  • [1] Contrast agents for MR imaging of the liver: A clinical overview
    Mahfouz, AE
    Hamm, B
    Taupitz, M
    EUROPEAN RADIOLOGY, 1997, 7 (04) : 507 - 513
  • [2] Contrast agents for MR imaging of the liver
    Low, RN
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01): : 56 - 67
  • [3] Contrast agents for MR imaging of the liver
    Semelka, RC
    Helmberger, TKG
    RADIOLOGY, 2001, 218 (01) : 27 - 38
  • [4] Contrast-enhanced MR imaging of the liver
    VanBeers, BE
    Gallez, B
    Pringot, J
    RADIOLOGY, 1997, 203 (02) : 297 - 306
  • [5] MR Imaging Contrast Agents Role in Imaging of Chronic Liver Diseases
    Chang, Silvia D.
    Cunha, Guilherme Moura
    Chernyak, Victoria
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2021, 29 (03) : 329 - 345
  • [6] Definition of liver tumors in the presence of diffuse liver disease: Comparison of findings at MR imaging with positive and negative contrast agents
    Kuwatsuru, R
    Brasch, RC
    Muhler, A
    Mathur, A
    Vexler, VS
    Rosenau, W
    Mintorovitch, J
    Berthezene, Y
    Cohen, F
    Shames, DM
    RADIOLOGY, 1997, 202 (01) : 131 - 138
  • [7] Novel MR imaging contrast agents for cancer detection
    Shahbazi-Gahrouei, Daryoush
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2009, 14 (03): : 141 - 147
  • [8] The Use of Contrast Agents in Clinical and Preclinical PET-MR Imaging
    Sandiford, Lydia
    de Rosales, Rafael T. M.
    PET CLINICS, 2016, 11 (02) : 119 - +
  • [9] Contrast-enhanced MR imaging of the heart: Overview of the literature
    Edelman, RR
    RADIOLOGY, 2004, 232 (03) : 653 - 668
  • [10] Mechanisms of action of liver contrast agents:: Impact for clinical use
    Clément, O
    Siauve, N
    Cuénod, CA
    Vuillemin-Bodaghi, V
    Leconte, I
    Frija, U
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1999, 23 : S45 - S52
12345